265 related articles for article (PubMed ID: 3059065)
1. The rise in testicular androgens during the first days of treatment with an LHRH agonist in the dog can be blocked by aminoglutethimide or ketoconazole.
Lacoste D; St-Arnaud R; Caron S; Belanger A; Labrie F
J Steroid Biochem; 1988 Dec; 31(6):963-70. PubMed ID: 3059065
[TBL] [Abstract][Full Text] [Related]
2. Effect of 3-week treatment with [D-Trp6, des-Gly-NH10(2)]LHRH ethylamide, aminoglutethimide, ketoconazole or flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog.
Lacoste D; Caron S; Bélanger A; Labrie F
J Steroid Biochem; 1989 Aug; 33(2):233-42. PubMed ID: 2671505
[TBL] [Abstract][Full Text] [Related]
3. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
[TBL] [Abstract][Full Text] [Related]
4. Effect of 2-week combination therapy with the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide and the antiandrogen flutamide on prostate structure and steroid levels in the dog.
Lacoste D; Dubé D; Bélanger A; Labrie F
Mol Cell Endocrinol; 1989 Dec; 67(2-3):131-8. PubMed ID: 2693158
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
6. A pure antiandrogen does not interfere with the LHRH agonist-induced blockade of testicular androgen secretion in the dog.
Lacoste D; St-Arnaud R; Bélanger A; Labrie F
Mol Cell Endocrinol; 1988 Mar; 56(1-2):141-7. PubMed ID: 3286322
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat.
Tremblay Y; Belanger A
J Steroid Biochem; 1985 Mar; 22(3):315-20. PubMed ID: 2581068
[TBL] [Abstract][Full Text] [Related]
8. Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.
Lefebvre FA; Bélanger A; Pelletier G; Labrie F
J Androl; 1984; 5(3):181-92. PubMed ID: 6086556
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Tremblay Y; Bélanger A; Labrie F; Frenette G; Dubé JY; Tremblay RR
Prostate; 1984; 5(6):631-8. PubMed ID: 6208541
[TBL] [Abstract][Full Text] [Related]
10. Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.
St-Arnaud R; Lachance R; Kelly SJ; Belanger A; Dupont A; Labrie F
Clin Endocrinol (Oxf); 1986 Jan; 24(1):21-30. PubMed ID: 3519004
[TBL] [Abstract][Full Text] [Related]
11. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.
Simard J; Labrie C; Hubert JF; Labrie F
Mol Endocrinol; 1988 Sep; 2(9):775-84. PubMed ID: 2459604
[TBL] [Abstract][Full Text] [Related]
12. Reversible inhibition of gonadal functions by a potent gonadotropin-releasing hormone agonist in adult dog.
Tremblay Y; Bélanger A
Contraception; 1984 Nov; 30(5):483-97. PubMed ID: 6394207
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.
Faure N; Labrie F; Belanger A; Lemay A; Raynaud JP; Von der Ohe M; Fazekas AT
J Endocrinol Invest; 1982; 5(6):355-60. PubMed ID: 6820372
[TBL] [Abstract][Full Text] [Related]
14. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
St Arnaud R; Lachance R; Dupont A; Labrie F
J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
[TBL] [Abstract][Full Text] [Related]
15. Normal gonadal functions and fertility after 23 months of treatment of prepubertal male and female dogs with the GnRh agonist [D-Trp6, des-Gly-NH2(10)]GnRH ethylamide.
Lacoste D; Dubé D; Trudel C; Bélanger A; Labrie F
J Androl; 1989; 10(6):456-65. PubMed ID: 2695507
[TBL] [Abstract][Full Text] [Related]
16. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
17. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat.
Lefebvre FA; Séguin C; Bélanger A; Caron S; Sairam MR; Raynaud JP; Labrie F
Prostate; 1982; 3(6):569-78. PubMed ID: 6296803
[TBL] [Abstract][Full Text] [Related]
18. The luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6, des-Gly-NH2(10)]-LHRH ethylamide, has no direct effect on spermatogenesis in the rat.
Dubé D; Pelletier G; Labrie F
Biol Reprod; 1988 Jun; 38(5):1165-70. PubMed ID: 3044454
[TBL] [Abstract][Full Text] [Related]
19. Pituitary function, ovarian follicular growth, and plasma concentrations of 17 beta-estradiol and progesterone in prepubertal heifers during and after treatment with the luteinizing hormone-releasing hormone agonist deslorelin.
Bergfeld EG; D'Occhio MJ; Kinder JE
Biol Reprod; 1996 Apr; 54(4):776-82. PubMed ID: 8924496
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of testicular androgen biosynthesis by chronic administration of a potent LHRH agonist in adult men.
Faure N; Lemay A
Arch Androl; 1985; 14(2-3):95-106. PubMed ID: 2933008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
